SCHEMBL6315677

SCHEMBL6315677

ON(CCl)c1cccc2cc[nH]c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 1/20 0.47
▸ KEAP1 Q14145 1/20 0.42
▸ BCHE P06276 4/20 0.42
▸ PDPK1 O15530 1/20 0.41
▸ BACE1 P56817 1/20 0.40
▸ NR3C1 P04150 1/20 0.35
▸ PGR P06401 1/20 0.35
▸ NR3C2 P08235 1/20 0.35
▸ AR P10275 1/20 0.35
▸ GRM5 P41594 1/20 0.35
▸ TNF P01375 1/20 0.33
▸ RIPK1 Q13546 1/20 0.33
▸ HDAC1 Q13547 2/20 0.32
▸ HDAC2 Q92769 2/20 0.32
▸ HDAC3 O15379 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ HDAC7 Q8WUI4 1/20 0.32
▸ HDAC10 Q969S8 1/20 0.32
▸ HDAC11 Q96DB2 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29082200 0.72 KDM4E (0.50) AHRKEAP1BCHEPDPK1BACE1
SCHEMBL18028982 0.71 BCHE (0.47) AHRKEAP1BCHEPDPK1BACE1
SCHEMBL28165786 0.68 KEAP1 (0.53) AHRKEAP1BCHEPDPK1BACE1
SCHEMBL28747176 0.66 AHR (0.43) AHRKEAP1BCHEPDPK1BACE1
SCHEMBL1544900 0.66 AHR (0.47) AHRKEAP1BCHEPDPK1BACE1
SCHEMBL24123642 0.66 KEAP1 (0.64) AHRKEAP1BCHEPDPK1BACE1
SCHEMBL12543495 0.66 AHR (0.47) AHRKEAP1BCHEPDPK1BACE1
SCHEMBL27757985 0.66 BCHE (0.45) AHRKEAP1BCHEPDPK1BACE1
SCHEMBL109665 0.65 AHR (0.56) AHRKEAP1BCHEPDPK1BACE1
SCHEMBL317549 0.65 AHR (0.56) AHRKEAP1BCHEPDPK1BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors MAP3K9, MAP3K19, MAP4K2 AHR 3200/4885KEAP1 2558/4885BCHE 2608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback